Suppr超能文献

非受体酪氨酸激酶信号在自身免疫中的作用及其治疗意义。

Non-receptor tyrosine kinase signaling in autoimmunity and therapeutic implications.

机构信息

Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.

Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.

出版信息

Pharmacol Ther. 2019 Sep;201:39-50. doi: 10.1016/j.pharmthera.2019.05.008. Epub 2019 May 11.

Abstract

Autoimmune diseases are characterized by impaired immune tolerance towards self-antigens, leading to enhanced immunity to self by dysfunctional B cells and/or T cells. The activation of these cells is controlled by non-receptor tyrosine kinases (NRTKs), which are critical mediators of antigen receptor and cytokine receptor signaling pathways. NRTKs transduce, amplify and sustain activating signals that contribute to autoimmunity, and are counter-regulated by protein tyrosine phosphatases (PTPs). The function of and interaction between NRTKs and PTPs during the development of autoimmunity could be key points of therapeutic interference against autoimmune diseases. In this review, we summarize the current state of knowledge of the functions of NRTKs and PTPs involved in B cell receptor (BCR), T cell receptor (TCR), and cytokine receptor signaling pathways that contribute to autoimmunity, and discuss their targeting for therapeutic approaches against autoimmune diseases.

摘要

自身免疫性疾病的特征是对自身抗原的免疫耐受受损,导致功能失调的 B 细胞和/或 T 细胞对自身产生增强的免疫。这些细胞的激活受非受体酪氨酸激酶(NRTKs)的控制,NRTKs 是抗原受体和细胞因子受体信号通路的关键介质。NRTKs 转导、放大和维持激活信号,有助于自身免疫,并受蛋白酪氨酸磷酸酶(PTPs)的反向调节。在自身免疫的发展过程中,NRTKs 和 PTPs 的功能和相互作用可能是针对自身免疫性疾病进行治疗干预的关键点。在这篇综述中,我们总结了参与 B 细胞受体(BCR)、T 细胞受体(TCR)和细胞因子受体信号通路的 NRTKs 和 PTPs 的功能的最新知识,这些通路有助于自身免疫,并讨论了针对自身免疫性疾病的治疗方法的靶向性。

相似文献

1
Non-receptor tyrosine kinase signaling in autoimmunity and therapeutic implications.
Pharmacol Ther. 2019 Sep;201:39-50. doi: 10.1016/j.pharmthera.2019.05.008. Epub 2019 May 11.
2
Protein tyrosine phosphatases in lymphocyte activation and autoimmunity.
Nat Immunol. 2012 Apr 18;13(5):439-47. doi: 10.1038/ni.2246.
3
Signaling mutations and autoimmunity.
Curr Dir Autoimmun. 2003;6:61-88. doi: 10.1159/000066856.
4
The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.
Expert Rev Clin Immunol. 2016 Jul;12(7):763-73. doi: 10.1586/1744666X.2016.1152888. Epub 2016 Mar 4.
5
Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity.
Immunology. 2012 Sep;137(1):1-19. doi: 10.1111/j.1365-2567.2012.03591.x.
8
Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases.
Semin Immunopathol. 2010 Jun;32(2):127-36. doi: 10.1007/s00281-010-0201-4. Epub 2010 Mar 4.
9
Lyn/CD22/SHP-1 and their importance in autoimmunity.
Curr Dir Autoimmun. 2002;5:151-60. doi: 10.1159/000060551.

引用本文的文献

1
Dasatinib-Induced Polymyositis-Like Syndrome: A Report of a Rare Case.
Cureus. 2025 Jun 20;17(6):e86457. doi: 10.7759/cureus.86457. eCollection 2025 Jun.
2
3
Targeted and untargeted metabolomics uncovering the effects of Jiawei Ermiao Granule on patients with persistent HPV infection.
Front Cell Infect Microbiol. 2025 Apr 7;15:1550908. doi: 10.3389/fcimb.2025.1550908. eCollection 2025.
4
Substrate-Mediated Regulation of Src Expression Drives Osteoclastogenesis Divergence.
Genes (Basel). 2024 Sep 18;15(9):1217. doi: 10.3390/genes15091217.
6
Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance.
Cancers (Basel). 2024 Aug 2;16(15):2754. doi: 10.3390/cancers16152754.
8
Adaptive immune cells are necessary for SARS-CoV-2-induced pathology.
Sci Adv. 2024 Jan 5;10(1):eadg5461. doi: 10.1126/sciadv.adg5461. Epub 2024 Jan 3.
10
Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective.
Signal Transduct Target Ther. 2022 Sep 17;7(1):329. doi: 10.1038/s41392-022-01168-8.

本文引用的文献

1
Thymic regulatory T cells arise via two distinct developmental programs.
Nat Immunol. 2019 Feb;20(2):195-205. doi: 10.1038/s41590-018-0289-6. Epub 2019 Jan 14.
2
ITK and RLK Inhibitor PRN694 Improves Skin Disease in Two Mouse Models of Psoriasis.
J Invest Dermatol. 2018 Apr;138(4):864-871. doi: 10.1016/j.jid.2017.10.029. Epub 2017 Nov 10.
3
Targeting interferons and their pathways in systemic lupus erythematosus.
Autoimmun Rev. 2018 Jan;17(1):44-52. doi: 10.1016/j.autrev.2017.11.009. Epub 2017 Nov 4.
4
Fostamatinib for persistent/chronic adult immune thrombocytopenia.
Immunotherapy. 2018 Jan;10(1):9-25. doi: 10.2217/imt-2017-0097. Epub 2017 Oct 2.
5
Stat3 as a potential therapeutic target for rheumatoid arthritis.
Sci Rep. 2017 Sep 8;7(1):10965. doi: 10.1038/s41598-017-11233-w.
7
The regulation of immune tolerance by FOXP3.
Nat Rev Immunol. 2017 Nov;17(11):703-717. doi: 10.1038/nri.2017.75. Epub 2017 Jul 31.
9
A novel BLK-induced tumor model.
Tumour Biol. 2017 Jul;39(7):1010428317714196. doi: 10.1177/1010428317714196.
10
Increased expression of Bruton's tyrosine kinase in peripheral blood is associated with lupus nephritis.
Clin Rheumatol. 2018 Jan;37(1):43-49. doi: 10.1007/s10067-017-3717-3. Epub 2017 Jun 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验